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Background/aims: Contaminated ophthalmic solutions represent a potential cause of avoidable ocular
infection. This study aimed to determine the magnitude and pattern of microbial contamination of multi-dose
ocular solutions at the Department of Ophthalmology, University of Nairobi, at the Kenyatta National
Hospital, Kenya.
Methods: 101 vials were obtained for microbial examination after an average use of 2 weeks. The dropper
tip and the residual eye drop were examined for contamination. The specimens were cultured, the number of
colonies counted, the organisms identified and susceptibility testing to selected antimicrobial agents was
done.
Results: Six (6%) of the 101 analysed vials were contaminated: 4/77 vials (5%) from a multi-user setting and
2/24 vials (8%) from a single user setting. Three contaminations (3/38, 8%) occurred in vials from the eye
ward, another three (3/59, 5%) in vials from the outpatient clinic. Most bacteria identified belonged to the
normal commensal flora of the eye. Isolated contaminants were micrococci (n = 2), Staphylococcus
epidermidis, Haemophilus sp, Bacillus sp and a Gram negative rod. The dropper tip was more often
contaminated (n = 6) than the residual solution (n = 1), and only one vial showed a contamination of both the
drop and the tip.
Conclusion: Our data show a contamination rate of 6%, which is in the lower range of data published on the
contamination of eye drops elsewhere (0.07% to 35.8%).
C
ontaminated eye drops and other ophthalmic solutions
are a potential cause of ocular infection. They can be
associated with keratitis1 and corneal ulcers2 and carry
the risk of transmitting opportunistic micro-organisms,3 4 as
well as pathogenic organisms, such as Pseudomonas aeruginosa
and Serratia marcescens.1 The published contamination rate of in-
use ophthalmic solutions varies widely in the literature from
0.07%5 to 35.8%.3 Apart from the risk of infection, bacterial
contamination of eye drops may alter the pH of the solution
and therefore reduce the efficacy of the drug.6
In order to prevent contamination, most preparations contain
antimicrobial substances, unless the solution itself has an
antimicrobial effect. These substances aim at preventing or
inhibiting the growth of micro-organisms which increase the
risk of infection or degradation of the drug. The self sterilising
effect of eye drops caused by the presence of preservatives has
been discussed controversially.7 Preservatives must meet several
requirements: (1) to be compatible with other ingredients; (2)
to be efficient during the entire duration of use of the eye drops;
and (3) to be non-toxic to the eye. Commonly used
preservatives of ophthalmic solutions are benzalkonium chlor-
ide, which also works as a detergent and therefore increases the
penetration of the active ingredient of the drug; thiomersal;
chlorhexidin; parahydroxy benzoate; phenylmercuric nitrate;
EDTA; chlorobutanol; benzyl alcohol; phenyl ethyl alcohol; and
parabens.8 9 As preservatives interfere with the metabolism and
inhibit the growth of micro-organisms, they may have similar
effects on human cells, explaining potential cytotoxic effects
and inflammatory cell responses.6 The antimicrobial activity is
important for the rate of infection resulting from contamina-
tion during the process of instillation. Contact with fingers or
lids, ciliaries, conjunctiva and cornea are possible causes of
contamination even if instilled by healthcare professionals.
Plastic bottles have been reported to be more commonly
contaminated near the bottle cap. This has been attributed to
a lack of preservative at this area.4 In a clinical study 220 in-use
medications of 101 patients with non-microbial ocular surface
disorders were examined by cultivating the bottle caps. The
authors concluded that a cycle of contamination between in-
use medications and conjunctiva may present an important risk
factor for microbial keratitis in patients with ocular surface
disease.10 The occurrence of bacterial ocular infection such as
keratits and endophthalmitis transmitted by contaminated eye
droppers has been reported.11 In a recent study the authors
noted that some cases of bacterial keratitis in Iran are thought
to be due to contaminated eye drops used on multiple
patients.12 Brudieu et al found a big difference in contamination
rates between vials used by ophthalmological patients (17.7%)
and vials used by medical and gerontological patients (35.8%).
A positive correlation was also found for vial contamination
and the duration of use. Vials containing an antimicrobial agent
were less likely to be contaminated than vials without
antimicrobials. However, no clinically relevant infection
through such vial contamination was identified.3 In a study
comparing the contamination rate of drops used in an eye
department and a nursing home no difference was found but
the authors stated that the residual eye drop is more often
contaminated than the tip of the bottle. They also noticed the
presence of Gram negative organisms in the nursing home.7
Most studies, however, found the bottle tips to be more often
contaminated than the solution.2 4 13 Therefore, topical eye
medications may present a potential risk of infection, especially
if the ocular epithelial barrier is compromised. Minimising the
contamination of eye drops and the transmission of infections
is an important issue in clinical ophthalmology. Several
regulations and suggestions have been made in this context.
Some suggest discarding eye drops in multiple use containers in
a domestic setting after 4 weeks of use and after 1 week in
Abbreviation: BHI, brain heart infusion
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hospital wards.14 With this in mind, we conducted the following
cross sectional study and analysed 101 ophthalmic solutions
examining bacterial and fungal contamination.
MATERIALS AND METHODS
In total, 101 containers were obtained for microbial examina-
tion. We distinguished between topical medications used by a
single patient and those used by several patients as well as
between different settings. All specimens were taken to the
Department of Microbiology, University of Nairobi at the
Kenyatta National Hospital, Kenya, and analysed the same
day in order to limit the effects of storage time and mimic the
clinical situation as closely as possible. Only eye drops with a
minimum use of 7 days were included, again to get a cross
sectional view of the medication used at the Department of
Ophthalmology. The microbial analysis was performed on both
the dropper tip and the residual eye drop for each container.
The specimens were obtained and cultured according to the
following protocol:
N A sterile cotton swab was moistened in sterile brain heart
infusion (BHI) before wiping the nozzle tip of the eye drop
containers and then used to inoculate the culture plates.
N The vials were inverted and one drop was directly inoculated
on each of the media and then spread across the plates.
All media except the Sabouraud agar plates were incubated
at 37 C˚ for 48 hours and evaluated after 24 and 48 hours. The
blood-agar, chocolate-blood agar plates were incubated in a
microaerophile environment.15 The Sabouraud agar plates were
incubated at 30 C˚ for up to 10 days and evaluated for growth on
days 1, 5 and 10. The BHI broth was also incubated at 37 C˚ and
subcultured on blood agar after 24 hours. All culture media
except Sabouraud dextrose agar (BioMe´rieux, F) were obtained
from Biotec Laboratories Ltd, UK.
A significant growth was considered a growth on the main
inoculation site or on two or more streaks on the plate. The BHI
was analysed for changes in colour and turbidity of the media.
The colonies on solid media were counted and all organisms
identified by microscopy after Gram staining and biochemical
tests. Bacteria were tested for susceptibility of antimicrobial
agents by the disc diffusion method using Mueller-Hinton agar
as media and antimicrobial discs (tetracycline, penicillin,
erythromycin, imipenem, vancomycin, gentamicin, chloram-
phenicol, norfloxacin, ciprofloxacin, cefazolin, cefotaxime) for
testing.
Cross tab analysis using exact Fisher’s test (SPSS for
Windows 14) was performed to determine statistically sig-
nificant differences between the multi-user, single user eye
drops, and for different settings (outpatient clinic, ward and
theatre).
RESULTS
A total of 101 medications were analysed; 77 from a multi-user
setting and 24 from a single user setting; 59 specimen were
obtained from the outpatient clinic, 38 from the ward and four
from the minor theatre. Table 1 shows the different, commonly
used preservatives found in the analysed specimens. The vials
were grouped in five different categories: mydriatics, tetracaine,
antibiotics, steroids, others. Overall, six (6%) of the 101
analysed vials were contaminated (table 2) at the bottle tip
alone or with additional contamination of the solution. A
contamination of the solution only without additional con-
tamination of the tip was not found in any specimen. Within
the five categories the rate of contamination varied between 0%
for antibiotics and 10% for tetracaine.
The dropper tip was more often contaminated (n = 6) than
the residual solution (n = 1). One bottle showed contamination
of both the dropper tip and the medical solution. The
contamination rate of antibiotic medication was 0 out of 18
(0%) while six (7%) of the 83 non-antibiotic vials were
contaminated.
Most of the identified organisms were part of the normal skin
or conjunctival flora. Gram positive organisms were cultivated
from four of the six contaminated medications (67%) and two
contaminated medications grew Gram negative organisms
(33%). Two out of the six contaminated medications showed
heavy growth with many colonies (33%) while the other four
yielded only a single colony on the main inoculum.
The contamination was 4/77 (5%) for the multi-user setting
and 2/24 (8%) for the single user setting (p.0.5). A
contamination of 3/38 (8%) was found in vials obtained from
the eye ward. Three of the 59 bottles taken from the outpatient
department (5%) were contaminated. No specimen obtained
from the minor theatre was found to be contaminated (p.0.5
in all cases). No fungal contamination was found in any
specimen.
No significant difference in contamination was found
between locally produced and imported drugs (p.0.5). The
Table 1 Preservatives (n = 101)
Preservative
Number of
medications
% of
medications
Chlorbutol IP 0.5% 18 18
Benzalconiumchloride 0.01% 59 58
Phenylmercuric nitrate IP
0.001%
11 11
Chlorhexidine acetate 1 1
Thiomersal IP 0.005% 3 3
None 9 9
Total 101
Table 2 Eye medications and contamination (n = 101)
Eye
medication
Number
tested Contaminated
Tip
contaminated
Tip/drop
contaminated
Drop
contaminated Contaminants
Mydriatics 56 4 (7%) 3 (5%) 1 (2%) Haemophilus spp,
Bacillus spp,
Micrococcus spp,
Staphylococcus
epidermidis
Tetracaine 10 1 (10.0%) 1 (10.0%) Micrococcus sp
Antibiotics 18 0
Steroids 14 1 (7%) 1 (7%) Gram negative rod
Others 3 0
Total 101 6 (6%) 5 (5%) 1 (1%)
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contamination for these two groups was 1/12 (8%) and 5/89
(6%) respectively.
None of the medications grew more than one type of
bacterium. Three of the 101 bottles (3%) were found to be past
the expiry date. None of these showed any bacterial growth.
Three other bottles did not have a clean and legible label, which
might suggest improper handling. However, none of these
bottles was contaminated.
Specimens where only little solution was left at the time of
analysis were not contaminated any more often than medica-
tions with a large amount of residual solution.
All identified bacteria were susceptible to imipenem, vanco-
mycin, gentamicin and ciprofloxacin, which proved to be the
most powerful antibiotic in this study. On the other hand some
commonly used antibiotics in Nairobi showed some lack in
effectiveness. Two of six bacteria were resistant to chloram-
phenicol, tetracycline, penicillin and cefotaxime (see table 4).
DISCUSSION
We noticed a microbial contamination of 6/101 (6%) of in-use
multiple application dispensers. The mean contamination rate
of preserved eye drops described in the literature varies widely
from 0.07%5 to 35.8%.3 Four of the six contaminated eye drops
only showed one single colony. These can be regarded as
occasional contamination16 and may be of limited clinical
relevance.
Five different micro-organisms were detected. As the con-
tainers were analysed on the day of collection, our results are
likely to represent the specific clinical situation of that day. A
slow self sterilising effect does not prevent the transmission of
micro-organisms from one patient to another if the medication
is used frequently with different patients—a situation not
uncommon for an ophthalmic outpatient department.
Four of six of the identified organisms were Gram positive
and 2/6 Gram negative. Most of the organisms were part of the
normal commensal flora of the conjunctiva or the skin. The
resident flora of the conjunctiva and eyelid mainly comprises of
Gram positive bacteria, including coagulase negative staphylo-
cocci, Corynebacterium spp, Propionibacterium spp, as well as
Staphylococcus aureus, Bacillus spp, Micrococcus spp and
Enterobacter spp.17 18 This is in accordance with several other
published studies.7 13 16 However, it differs from results pub-
lished by Rahman et al,19 who found only a small proportion of
the micro-organisms identified to be part of the normal
commensal flora when studying the contamination of unpre-
served eye drops.
A cycle of contamination between the lids and dropper tips
was suggested by Schein at al.10 The contamination of eye drops
and eye drop dispenser with the same micro-organism,
especially Gram negative, has been described by the same
group. This represents a potentially serious risk for ocular
infection, especially in cases of compromised corneal epithe-
lium as in extensive contact lens wear, ocular trauma or the use
of topical steroids.
In this study pathogenic organisms were rare and showed
limited growth that probably did not represent a clinically
relevant risk of infection.
The contamination rates of the setting of the eye ward (3/38,
8%) were not significantly different from the setting in the
outpatient department (3/59, 5%). even though patient
characteristics were different in the two settings: in the
outpatient department, mostly mydriatics and local anaes-
thetics are used for diagnostic purposes, whereas in the eye
ward many inpatients received specific topical eye treatment.
Mydriatics, especially in the outpatient department, are used
frequently and used quickly as part of routine eye examina-
tions.
We did not find any significant difference in the contamina-
tion rate of eye drops/dropper tips and the residual volume
which was left in the bottle. This supports the previously
described self sterilising effect of many eye medications. We
therefore conclude that the risk of transmitting micro-organ-
isms may depend on the frequency of shared eye medications in
a multi-user setting.
Another relevant factor might be differences in the admin-
istration of eye drops. In the setting of the Department of
Ophthalmology, University of Nairobi, Kenyatta National
Hospital, Nairobi, Kenya, this task is performed by ophthalmol-
ogists and postgraduate students in the outpatient department
and nurses in the eye ward. This regular involvement of
qualified eye care personnel might contribute to the overall low
rate of contamination.
The design of the containers might also influence contam-
ination. Only bottles with a tip attached to the bottle itself were
analysed in this study. The bottle tips were more often
contaminated (n = 6) than residual drops (n = 1), with con-
tamination of both the tip and the residual solution appearing
in only one specimen. These results are similar to the ones
Table 3 Contaminated medications and preservatives
Eye medication
Bottle size/
tube size Preservative Contaminant
Tropicamide 0.8% with
phenylephrine 5%
5 ml Chlorbutol IP 0.5% Micrococcus sp
Cyclopentolate 1%,
Phenylephrine 10%
5 ml None Bacillus anthracoides
Tropicamide 1% 5 ml Phenylmercuric nitrate IP 0.001% Staphylococcus epidermidis
Tropicamide 1% 15 ml Benzalconiumchloride 0.01% Haemophilus sp.
Tetracaine 0,5% 15 ml Benzalconiumchloride 0.01% Micrococcus sp
Dexamethasone Phosphate 0.1% 5 ml Benzalconiumchloride 0.01% Gram negative rod
Table 4 Antibiotic susceptibility pattern of bacterial
isolates (n = 6 tested)
Susceptible Intermediate Resistant
Tetracycline 4 2
Penicillin 3 1 2
Erythromycin 4 2
Imipenem 6
Vancomycin 6
Gentamicin 6
Chloramphenicol 4 2
Norfloxacin 5 1
Ciprofloxacin 6
Cefazolin 5 1
Cefotaxime 4 2
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reported in earlier studies.11 13 16 One reason for this pattern to
be considered is the antimicrobial activity of preservatives or of
the solution itself in antibiotic drops. Such antimicrobial
effects, however, may not act sufficiently on the tip itself as
the contact time is limited. Further, the tip provides a large
surface for contamination from ocular structures or hands.
Even dried crusts can sometimes be found on the bottle tips.
The removal of such remnants with a sterile swab might further
reduce the contamination rate.4 However, the contamination of
the solution itself has to be regarded as clinically more relevant
since these get in direct contact with the patient’s eye.
It is not possible to establish the exact contamination rates of
each individual product in this study as the total number of
specimens is not sufficient and the variety of different
medications too great for this purpose. However, the contam-
ination rates of commercially available (5/89, 6%) and locally
produced (1/12, 8%) medications were comparably low in our
study. This is particularly relevant for the situation in
developing and emerging nations where drugs are increasingly
produced locally to reduce costs.
The number of expired eye drops, 3/101 (3%), in our study is
relatively low in comparison to the 20% of the bottles examined
by Wessels et al.5 We recommend not storing any open bottles in
the back of drawers or on top shelves but always keeping them
handy and limited to those actually needed. Furthermore, we
recommend noting the date of first opening on each container,
as the duration of use might be another and possibly
more relevant parameter in this context rather than the expiry
date.5
Conclusion
The results of this study support the importance of a proper set
of rules and the correct handling and application of eye
medications in multi-user settings. Healthcare providers and
patients should be carefully trained and informed as to how to
administer eye medications. Patients who are unable to use eye
drops in an aseptic way because of age or other physical (for
example, poor vision) or mental limitations should be assisted
by competent relatives or caretakers.
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